Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Chen, Xi ^a   Burgoyne, Robert D ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A OXIDASE; ALPHA SYNUCLEIN; CHAPERONE; HISTONE DEACETYLASE; POLYGLUTAMINE; TAU PROTEIN; UBIQUITIN PROTEIN LIGASE E3; OXIDOREDUCTASE; PEROXISOMAL ACYL COA OXIDASE; PEROXISOMAL ACYL-COA OXIDASE; UBIQUITIN PROTEIN LIGASE;

ARTICLE; AUTOPHAGY; BIOSYNTHESIS; BLI 3 GENE; CAENORHABDITIS ELEGANS; CATP 6 GENE; CCT 4 GENE; CCT 5 GENE; CDC 48.1 GENE; CHN 1 GENE; CONTROLLED STUDY; CTBP 1 GENE; DEGENERATIVE DISEASE; DHC 1 GENE; DNA REPAIR; DNA REPLICATION; DNJ 13 GENE; DROSOPHILA MELANOGASTER; ENERGY METABOLISM; EXTRACELLULAR MATRIX; F59F4.1 GENE; FFT 2 GENE; GENE EXPRESSION REGULATION; GENE PRODUCT; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC SCREENING; H18N13.2 GENE; HAD 1 GENE; HSF 1 GENE; HSP 1 GENE; HUMAN; HUMAN CELL; KIN 18 GENE; LET 19 GENE; LET 70 GENE; LIPID METABOLISM; MDT 17 GENE; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; NPP 18 GENE; OXIDATIVE STRESS; PAR 5 GENE; PATHOGENESIS; PHI 49 GENE; PMR 1 GENE; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; RAB 1 GENE; RNA BINDING; RNA PROCESSING; RNA TRANSLATION; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; SIN 3 GENE; SIR2.1 GENE; STF 4 GENE; SYNAPTIC TRANSMISSION; TBC 20 GENE; TRANS GOLGI NETWORK; TRANSCRIPTION REGULATION; UAF 2 GENE; UBC 8 GENE; UNC 11 GENE; UNC 26 GENE; VHA 15 GENE; XPO 1 GENE; YKT 6 GENE; ANIMAL; ANIMAL MODEL; GENETICS; META ANALYSIS; METABOLISM; PHENOTYPE;

CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER;

ANIMALS; CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; HISTONE DEACETYLASES; MODELS, ANIMAL; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES; OXIDOREDUCTASES; PHENOTYPE; SACCHAROMYCES CEREVISIAE; UBIQUITIN-PROTEIN LIGASES;

EID: 84857015643     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-71     Document Type: Article

References (80)

1. Voisine C, Pedersen JS, Morimoto RI. Chaperone networks: Tipping the balance in protein folding diseases. Neurobiol Dis 2010, 40(1):12-20. 10.1016/j.nbd.2010.05.007, 20472062.
2. Gandhi S, Wood NW. Genome-wide association studies: the key to unlocking neurodegeneration?. Nat Neurosci 2010, 13(7):789-794. 10.1038/nn.2584, 20581814.
3. Kearney JA. Genetic modifiers of neurological disease. Current Opinion in Genetics & Development 2011, 21(3):349-353. 10.1016/j.gde.2010.12.007, 22280100.
4. Brignull HR, Morley JF, Morimoto RI. The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging. Adv Exp Med Biol 2007, 594:167-189. 10.1007/978-0-387-39975-1_15, 17205684.
5. Teschendorf D, Link C. What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?. Mol Neurodegener 2009, 4(1):1-13. 10.1186/1750-1326-4-1, 2654562, 19126211.
6. Harrington AJ, Hamamichi S, Caldwell GA, Caldwell KA. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease. Dev Dyn 2010, 239(5):1282-1295.
7. Link CD. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 1995, 92(20):9368-9372. 10.1073/pnas.92.20.9368, 40986, 7568134.
8. Kuwahara T, Koyama A, Gengyo-Ando K, Masuda M, Kowa H, Tsunoda M, Mitani S, Iwatsubo T. Familial Parkinson Mutant α-Synuclein Causes Dopamine Neuron Dysfunction in Transgenic Caenorhabditis elegans. J Biol Chem 2006, 281(1):334-340.
9. van Ham TJ, Thijssen KL, Breitling R, Hofstra RMW, Plasterk RHA, Nollen EAA. C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During Aging. PLoS Genet 2008, 4(3):e1000027. 10.1371/journal.pgen.1000027, 2265412, 18369446.
10. Nollen EA, Garcia SM, van Haaften G, Kim S, Chavez A, Morimoto RI, Plasterk RH. Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci USA 2004, 101(17):6403-6408. 10.1073/pnas.0307697101, 404057, 15084750.
11. Wang J, Farr GW, Hall DH, Li F, Furtak K, Dreier L, Horwich AL. An ALS-Linked Mutant SOD1 Produces a Locomotor Defect Associated with Aggregation and Synaptic Dysfunction When Expressed in Neurons of Caenorhabditis elegans. PLoS Genet 2009, 5(1):e1000350. 10.1371/journal.pgen.1000350, 2621352, 19165329.
12. Faber PW, Voisine C, King DC, Bates EA, Hart AC. Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity. Proc Natl Acad Sci USA 2002, 99(26):17131-17136. 10.1073/pnas.262544899, 139281, 12486229.
13. Parker JA, Metzler M, Georgiou J, Mage M, Roder JC, Rose AM, Hayden MR, Neri C. Huntingtin-interacting protein 1 influences worm and mouse presynaptic function and protects Caenorhabditis elegans neurons against mutant polyglutamine toxicity. J Neurosci 2007, 27(41):11056-11064. 10.1523/JNEUROSCI.1941-07.2007, 17928447.
14. Kraemer BC, Burgess JK, Chen JH, Thomas JH, Schellenberg GD. Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans. Hum Mol Genet 2006, 15(9):1483-1496. 10.1093/hmg/ddl067, 16600994.
15. Rubinsztein D. Functional genomics approaches to neurodegenerative diseases. Mammalian Genome 2008, 19(9):587-590. 10.1007/s00335-008-9130-0, 18665420.
16. Lessing D, Bonini NM. Maintaining the brain: insight into human neurodegeneration from Drosophila melanogaster mutants. Nat Rev Genet 2009, 10(6):359-370. 10.1038/nrg2563, 2820605, 19434080.
17. van Ham TJ, Breitling R, Swertz MA, Nollen EAA. Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms. EMBO Molecular Medicine 2009, 1(8-9):360-370.
18. Moloney A, Sattelle DB, Lomas DA, Crowther DC. Alzheimer's disease: insights from Drosophila melanogaster models. Trends in biochemical sciences 2010, 35(4):228-235. 10.1016/j.tibs.2009.11.004, 2856915, 20036556.
19. Johnson JR, Jenn RC, Barclay JW, Burgoyne RD, Morgan A. Caenorhabditis elegans: a useful tool to decipher neurodegenerative pathways. Biochem Soc Trans 2010, 38(2):559-563. 10.1042/BST0380559, 20298221.
20. Mallik M, Lakhotia SC. Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models. J Genet 2010, 89(4):497-526. 10.1007/s12041-010-0072-4, 21273704.
21. Doumanis J, Wada K, Kino Y, Moore AW, Nukina N. RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation. PLoS ONE 2009, 4(9):e7275. 10.1371/journal.pone.0007275, 2748703, 19789644.
22. Zhang S, Binari R, Zhou R, Perrimon N. A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 2010, 184(4):1165-1179. 10.1534/genetics.109.112516, 2865916, 20100940.
23. Teuling E, Bourgonje A, Veenje S, Thijssen K, de Boer J, van der Velde J, Swertz M, Nollen E. Modifiers of mutant huntingtin aggregation: functional conservation of C. elegans-modifiers of polyglutamine aggregation. PLoS Curr 2011, 3:RRN1255. 3166184, 21915392.
24. Willingham S, Outeiro TF, DeVit MJ, Lindquist SL, Muchowski PJ. Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein. Science 2003, 302(5651):1769-1772. 10.1126/science.1090389, 14657499.
25. Schulte J, Sepp KJ, Wu C, Hong P, Littleton JT. High-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease model. PLoS ONE 2011, 6(8):e23841. 10.1371/journal.pone.0023841, 3166080, 21909362.
26. Heinicke S, Livstone MS, Lu C, Oughtred R, Kang F, Angiuoli SV, White O, Botstein D, Dolinski K. The Princeton Protein Orthology Database (P-POD): a comparative genomics analysis tool for biologists. PLoS ONE 2007, 2(8):e766. 10.1371/journal.pone.0000766, 1942082, 17712414.
27. Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature 2011, 475(7356):324-332. 10.1038/nature10317, 21776078.
28. Soss SE, Yue Y, Dhe-Paganon S, Chazin WJ. E2 conjugating enzyme selectivity and requirements for function of the E3 ubiquitin ligase CHIP. J Biol Chem 2011, 286(24):21277-21286. 10.1074/jbc.M111.224006, 21518764.
29. van Wijk SJ, de Vries SJ, Kemmeren P, Huang A, Boelens R, Bonvin AM, Timmers HT. A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system. Mol Syst Biol 2009, 5:295. 2736652, 19690564.
30. Hatakeyama S, Matsumoto M, Yada M, Nakayama KI. Interaction of U-box-type ubiquitin-protein ligases (E3s) with molecular chaperones. Genes Cells 2004, 9(6):533-548. 10.1111/j.1356-9597.2004.00742.x, 15189447.
31. Kalia LV, Kalia SK, Chau H, Lozano AM, Hyman BT, McLean PJ. Ubiquitinylation of alpha-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5). PLoS ONE 2011, 6(2):e14695. 10.1371/journal.pone.0014695, 3040167, 21358815.
32. Al-Ramahi I, Lam YC, Chen HK, de Gouyon B, Zhang M, Perez AM, Branco J, de Haro M, Patterson C, Zoghbi HY, et al. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. J Biol Chem 2006, 281(36):26714-26724. 10.1074/jbc.M601603200, 16831871.
33. Imai Y, Soda M, Hatakeyama S, Akagi T, Hashikawa T, Nakayama KI, Takahashi R. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell 2002, 10(1):55-67. 10.1016/S1097-2765(02)00583-X, 12150907.
34. Branco J, Al-Ramahi I, Ukani L, Perez AM, Fernandez-Funez P, Rincon-Limas D, Botas J. Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases. Hum Mol Genet 2008, 17(3):376-390.
35. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, et al. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 1997, 387(6628):43-48. 10.1038/387043a0, 9139820.
36. Alland L, Muhle R, Hou H, Potes J, Chin L, Schreiber-Agus N, DePinho RA. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 1997, 387(6628):49-55. 10.1038/387049a0, 9139821.
37. Bates EA, Victor M, Jones AK, Shi Y, Hart AC. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. J Neurosci 2006, 26(10):2830-2838. 10.1523/JNEUROSCI.3344-05.2006, 16525063.
38. Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001, 410(6825):227-230. 10.1038/35065638, 11242085.
39. Wang Y, Tissenbaum HA. Overlapping and distinct functions for a Caenorhabditis elegans SIR2 and DAF-16/FOXO. Mech Ageing Dev 2006, 127(1):48-56. 10.1016/j.mad.2005.09.005, 16280150.
40. Mair W, Dillin A. Aging and survival: the genetics of life span extension by dietary restriction. Annu Rev Biochem 2008, 77:727-754. 10.1146/annurev.biochem.77.061206.171059, 18373439.
41. Burnett C, Valentini S, Cabreiro F, Goss M, Somogyvari M, Piper MD, Hoddinott M, Sutphin GL, Leko V, McElwee JJ, et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 2011, 477(7365):482-485. 10.1038/nature10296, 21938067.
42. Jadiya P, Chatterjee M, Sammi SR, Kaur S, Palit G, Nazir A. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: Implications for Parkinson's disease. Biochem Biophys Res Commun 2011,
43. D'Mello SR. Histone deacetylases as targets for the treatment of human neurodegenerative diseases. Drug News Perspect 2009, 22(9):513-524. 10.1358/dnp.2009.22.9.1437959, 20072728.
44. Herranz D, Serrano M. SIRT1: recent lessons from mouse models. Nat Rev Cancer 2010, 10(12):819-823. 10.1038/nrc2962, 21102633.
45. Dietz KC, Casaccia P. HDAC inhibitors and neurodegeneration: at the edge between protection and damage. Pharmacol Res 2010, 62(1):11-17. 10.1016/j.phrs.2010.01.011, 2871984, 20123018.
46. Yacoubian TA, Slone SR, Harrington AJ, Hamamichi S, Schieltz JM, Caldwell KA, Caldwell GA, Standaert DG. Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death Dis 2010, 1:e2. 10.1038/cddis.2009.4, 2998343,2998343, 21152247.
47. Wang Y, Oh SW, Deplancke B, Luo J, Walhout AJ, Tissenbaum HA. C. elegans 14-3-3 proteins regulate life span and interact with SIR-2.1 and DAF-16/FOXO. Mech Ageing Dev 2006, 127(9):741-747. 10.1016/j.mad.2006.05.005, 16860373.
48. Berdichevsky A, Viswanathan M, Horvitz HR, Guarente L. C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell 2006, 125(6):1165-1177. 10.1016/j.cell.2006.04.036, 16777605.
49. Slone SR, Lesort M, Yacoubian TA. 14-3-3theta protects against neurotoxicity in a cellular Parkinson's disease model through inhibition of the apoptotic factor Bax. PLoS ONE 2011, 6(7):e21720. 10.1371/journal.pone.0021720, 3140482, 21799745.
50. Giorgini F, Guidetti P, Nguyen Q, Bennett SC, Muchowski PJ. A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nature genetics 2005, 37(5):526-531. 10.1038/ng1542, 1449881, 15806102.
51. Zwilling D, Huang SY, Sathyasaikumar KV, Notarangelo FM, Guidetti P, Wu HQ, Lee J, Truong J, Andrews-Zwilling Y, Hsieh EW, et al. Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell 2011, 145(6):863-874. 10.1016/j.cell.2011.05.020, 21640374.
52. Campesan S, Green EW, Breda C, Sathyasaikumar KV, Muchowski PJ, Schwarcz R, Kyriacou CP, Giorgini F. The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease. Curr Biol 2011, 21(11):961-966. 10.1016/j.cub.2011.04.028, 21636279.
53. Rubinsztein DC, Marino G, Kroemer G. Autophagy and aging. Cell 2011, 146(5):682-695. 10.1016/j.cell.2011.07.030, 21884931.
54. Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, Lichtenberg M, Menzies FM, Ravikumar B, Imarisio S, et al. alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease. J Cell Biol 2010, 190(6):1023-1037. 10.1083/jcb.201003122, 3101586, 20855506.
55. Winslow AR, Rubinsztein DC. Autophagy in neurodegeneration and development. Biochim Biophys Acta 2008, 1782(12):723-729. 2597715, 18644437.
56. Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 2010, 13(7):805-811. 10.1038/nn.2575, 20581817.
57. Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, Tsokos M, Alt FW, Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA 2008, 105(9):3374-3379. 10.1073/pnas.0712145105, 2265142, 18296641.
58. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K, Strathearn KE, Liu F, et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006, 313(5785):324-328. 10.1126/science.1129462, 1983366, 16794039.
59. Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ, Caldwell KA, Caldwell GA, Cooper AA, Rochet J-C, et al. [alpha]-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nature genetics 2009, 41(3):308-315. 10.1038/ng.300, 2683786, 19182805.
60. Treusch S, Hamamichi S, Goodman JL, Matlack KE, Chung CY, Baru V, Shulman JM, Parrado A, Bevis BJ, Valastyan JS, et al. Functional Links Between Abeta Toxicity, Endocytic Trafficking, and Alzheimer's Disease Risk Factors in Yeast. Science 2011, 334(6060):1241-1245. 10.1126/science.1213210, 22033521.
61. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009, 41(10):1088-1093. 10.1038/ng.440, 2845877, 19734902.
62. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009, 41(10):1094-1099. 10.1038/ng.439, 19734903.
63. Bilen J, Bonini NM. Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet 2007, 3(10):1950-1964. 2041992, 17953484.
64. Gurvitz A, Langer S, Piskacek M, Hamilton B, Ruis H, Hartig A. Predicting the function and subcellular location of Caenorhabditis elegans proteins similar to Saccharomyces cerevisiae beta-oxidation enzymes. Yeast 2000, 17(3):188-200. 10.1002/1097-0061(20000930)17:3<188::AID-YEA27>3.0.CO;2-E, 2448379, 11025529.
65. Hamamichi S, Rivas RN, Knight AL, Cao S, Caldwell KA, Caldwell GA. Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proc Natl Acad Sci USA 2008, 105(2):728-733. 10.1073/pnas.0711018105, 2206604, 18182484.
66. Ferdinandusse S, Denis S, Hogenhout EM, Koster J, van Roermund CW, L IJ, Moser AB, Wanders RJ, Waterham HR. Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Hum Mutat 2007, 28(9):904-912. 10.1002/humu.20535, 17458872.
67. Li L, Stoeckert CJ, Roos DS. OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res 2003, 13(9):2178-2189. 10.1101/gr.1224503, 403725, 12952885.
68. Kuwahara T, Koyama A, Koyama S, Yoshina S, Ren C-H, Kato T, Mitani S, Iwatsubo T. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in α-synuclein transgenic C. elegans. Hum Mol Genet 2008, 17(19):2997-3009. 10.1093/hmg/ddn198, 18617532.
69. Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A. Opposing activities protect against age-onset proteotoxicity. Science 2006, 313(5793):1604-1610. 10.1126/science.1124646, 16902091.
70. Kraemer BC, Schellenberg GD. SUT-1 enables tau-induced neurotoxicity in C. elegans. Hum Mol Genet 2007, 16(16):1959-1971. 10.1093/hmg/ddm143, 17576746.
71. Guthrie CR, Schellenberg GD, Kraemer BC. SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans. Hum Mol Genet 2009, 18(10):1825-1838. 10.1093/hmg/ddp099, 2722225, 19273536.
72. Yamanaka K, Okubo Y, Suzaki T, Ogura T. Analysis of the two p97/VCP/Cdc48p proteins of Caenorhabditis elegans and their suppression of polyglutamine-induced protein aggregation. J Struct Biol 2004, 146(1-2):242-250. 10.1016/j.jsb.2003.11.017, 15037255.
73. Yeger-Lotem E, Riva L, Su LJ, Gitler AD, Cashikar AG, King OD, Auluck PK, Geddie ML, Valastyan JS, Karger DR, et al. Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity. Nature genetics 2009, 41(3):316-323. 10.1038/ng.337, 2733244, 19234470.
74. Blard O, Feuillette S, Bou J, Chaumette B, Frebourg T, Campion D, Lecourtois M. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila. Hum Mol Genet 2007, 16(5):555-566. 10.1093/hmg/ddm011, 17309878.
75. Kaltenbach LS, Romero E, Becklin RR, Chettier R, Bell R, Phansalkar A, Strand A, Torcassi C, Savage J, Hurlburt A, et al. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet 2007, 3(5):e82. 10.1371/journal.pgen.0030082, 1866352, 17500595.
76. Shulman JM, Feany MB. Genetic modifiers of tauopathy in Drosophila. Genetics 2003, 165(3):1233-1242. 1462852, 14668378.
77. Ghosh S, Feany MB. Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases. Hum Mol Genet 2004, 13(18):2011-2018. 10.1093/hmg/ddh214, 15254017.
78. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 2000, 408(6808):101-106. 10.1038/35040584, 11081516.
79. Kazemi-Esfarjani P, Benzer S. Genetic suppression of polyglutamine toxicity in Drosophila. Science 2000, 287(5459):1837-1840. 10.1126/science.287.5459.1837, 10710314.
80. Auluck PK, Chan HYE, Trojanowski JQ, Lee VM-Y, Bonini NM. Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease. Science 2002, 295(5556):865-868. 10.1126/science.1067389, 11823645.